MAR 13, 2017 07:48 PM PDT

Physical Activity Helps Patients Undergoing GI Cancer Chemotherapy

WRITTEN BY: Carmen Leitch

Research has shown that patients with advanced gastrointestinal cancer can use walking or jogging to help deal with the side effects they experience from chemotherapy. In people undergoing chemotherapy, exercise had a beneficial effect on balance, muscles and tumor-related fatigue syndrome. Not only did patients show a better tolerance for the chemo, they had less disease relapses later. This work replicates other studies showing the same effects, (the benefits of exercise to people with many types of cancer is outlined in the video below from Mayo Clinic) but this work has differentiated between several kinds of tumors and different stages of illness.

The study was a collaboration between the Department of Sports Medicine led by Professor Winfried Banzer and of Medical Clinic I along with the Gastrointestinal Centre of Agaplesion Markus Hospital in Frankfurt, both led by Professor Axel Dignaß. They have shown that in patients with an advanced gastrointestinal tumor, exercise therapy can be a benefit. In agreement with American College of Sports Medicine recommendations, the participants either exercised three times a week for 50 minutes or five times a week for 30 minutes at a pace that they deemed "slightly strenuous". If this became too difficult to manage, the patents were able to then reduce their exercise sessions along with the guidelines of a standardized model.

"For some patients, it was difficult to carry out the walking or jogging program in accordance with the recommendations," explained Katrin Stücher, completing this work as her doctorate in the Department of Sports Medicine of Goethe University Frankfurt. "A frequent obstacle was the weather: either it was too cold, too hot or too wet. But the side effects of the chemotherapy, such as loss of sensation, weakness, exhaustion, infections or severe diarrhea, also often meant that they had to reduce or even discontinue the program."

Wile study participants periodically feel the need to take breaks, the complementary exercise therapy was worth the effort. There was not only an improvement in muscle mass but also an improvement in function like walking speed, leg strength and balance. There was an indication from this work that the toxic effects of chemotherapy can be mitigated through moderate physical activity. Patients undergoing chemotherapy for gastrointestinal cancer often have to reduce or totally halt chemotherapy because of toxicity, so this work could prove valuable to those patients.

"I go walking every morning. It's good for both my mind and my body and I'm sure it's contributing to my recovery. I think that if you hadn't encouraged me to continue exercising I would probably not have dared to push myself so far physically," one participant reported to Stücher.

"We believe that it will make sense in future to offer patients opportunities for physical exercise during chemotherapy. To eliminate adversities through the weather, exercise rooms could be set up in hospitals. In addition, we should motivate patients to continue with the program after they have taken a break because of side effects," concluded Professor Winfried Banzer, the Head of the Department of Sports Medicine at Goethe University Frankfurt.

For more information about the study, check out ClinicalTrials.gov.

 

The video above from Memorial Sloan Kettering is about the benefits of physical activity for cancer survivors.

Sources: AAAS/Eurekalert! via Goethe University Frankfurt

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 16, 2018
Cancer
JUN 16, 2018
Lung Cancer Rates Increasing in White and Hispanic Young Women
Lung cancer has long been tied to smoking and had a higher incidence in men than women. A new study shows rates of lung cancer are increasing in some groups of young women....
JUN 26, 2018
Cancer
JUN 26, 2018
Five "-omics" Fields Introduced
An introduction to genomics, transcriptomics, proteomics, epigenomics, and metabolomics....
AUG 08, 2018
Immunology
AUG 08, 2018
Doxorubicin Causes Heart Toxicity by Immune System Disruption
Chemotherapy drug Doxorubicin disrupts metabolism that controls immune responses in the heart leading to heart toxicity....
SEP 12, 2018
Microbiology
SEP 12, 2018
Researchers ID a Link Between a Bacterial Strain and Gastric Cancer
Helicobacter pylori is a bacterium that causes stomach ulcers, and can lead to gastric cancer....
OCT 04, 2018
Genetics & Genomics
OCT 04, 2018
Similar Processes Drive the Development of Lung and Prostate Cancers
Small cell cancers often have poor prognoses....
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
Loading Comments...